Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Reconstructing the tumor microenvironment to unlock therapeutic options in pancreatic cancer.
Authors
Ben George
Froedtert & The Medical College of Wisconsin, Milwaukee, WI
Ben George , Samih Thalji , Subramaniam Malarkannan , Olga Kudryashova , Andrey Kravets , Mariia Gusakova , Dmitry Kravchenko , Dmitry Tychinin , Felix Frenkel , Aleksander Bagaev , Nara Shin , Maahum Mehdi , Mandana Kamgar , William A. Hall , Beth Erickson , Kathleen K. Christians , Douglas B. Evans , Susan Tsai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Translational Research
DOI
10.1200/JCO.2022.40.4_suppl.589
Abstract #
589
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC): Preliminary findings.
First Author: Benjamin Adam Weinberg
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A transcriptomic approach to explore the immune landscape of patient with pancreatic ductal adenocarcinoma with prognostic impact.
First Author: Jose Antonio Lopez Guerrero
Poster
2023 ASCO Annual Meeting
Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC).
First Author: Benjamin Adam Weinberg
Poster
2023 ASCO Annual Meeting
Molecular and clinical correlates of DSCR1 expression in pancreatic cancer (PDAC).
First Author: Francesca Battaglin